Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Audit-C Questionnaire

May 30, 2017/Test & Measure

Identifies people who are hazardous drinkers or who have active alcohol use disorders, including alcohol abuse or dependence.

Global Deterioration Scale for Assessment of Primary Degenerative Dementia (GDS)

Aug 22, 2017/Test & Measure

A quick screening tool to detect the early onset of dementia as well as the severity of the condition.

Code of Ethics for the Physical Therapy Profession

Jan 1, 2026/Policies & Bylaws

The vision of the American Physical Therapy Association is "transforming society by optimizing movement to improve the human experience." Our profession’s charge, as we strive to be an inclusive moral community that is diverse and equitable, is to meet the health needs of all people.

Pelvic Health Physical Therapy

Pelvic health physical therapy is a vital part of recovery in the postpartum period.

It Takes a Moose, Sometimes

Mar 1, 2016/Column

A reminder of the power of community.

Congress Approves Temporary Spending Deal With No Fee Schedule Relief

Jan 19, 2024/News

The stopgap agreement expires in March, setting up another opportunity to press for a fee schedule fix.

Congress Introduces APTA-Supported Bill to Increase Payment Under 2025 Medicare Fee Schedule

Oct 29, 2024/News

In anticipation of the 2025 fee schedule final rule, a new bipartisan bill would change an expected 2.8% cut to a 1.9% increase.

From Students to Fellows: Celebrating Leadership Across the Profession

Nov 1, 2025/Feature

Meet the seasoned leaders, emerging trailblazers, and outstanding students who are driving the profession forward.

APTA President’s Note | Where We Are Supposed to Be

Nov 1, 2025/Column

APTA President Kyle Covington, PT, DPT, PhD, recalls a memorable patient encounter in this issue’s column.

Weighty Matters: Physical Therapy and GLP-1 Medications

Aug 1, 2025/Feature

What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.